TGFBR2 and cancer: Increased H3K9 acetylation was observed on the promoter of Transforming Growth Factor Beta Receptor 2 (TGFBR2) after the activation of SNAI1/2, leading to transcription of TGF-β, a major player in the regulation of cancer metastasis [15].